[go: up one dir, main page]

MX2018014889A - Peliculas a base de plasma y metodos para elaborar y usar las mismas. - Google Patents

Peliculas a base de plasma y metodos para elaborar y usar las mismas.

Info

Publication number
MX2018014889A
MX2018014889A MX2018014889A MX2018014889A MX2018014889A MX 2018014889 A MX2018014889 A MX 2018014889A MX 2018014889 A MX2018014889 A MX 2018014889A MX 2018014889 A MX2018014889 A MX 2018014889A MX 2018014889 A MX2018014889 A MX 2018014889A
Authority
MX
Mexico
Prior art keywords
based films
plasma
making
methods
same
Prior art date
Application number
MX2018014889A
Other languages
English (en)
Inventor
Grant Ericson Daniel
Original Assignee
Octapharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Octapharma Ag filed Critical Octapharma Ag
Publication of MX2018014889A publication Critical patent/MX2018014889A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/40—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing ingredients of undetermined constitution or reaction products thereof, e.g. plant or animal extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/38—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/005—Ingredients of undetermined constitution or reaction products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/043—Proteins; Polypeptides; Degradation products thereof
    • A61L31/047—Other specific proteins or polypeptides not covered by A61L31/044 - A61L31/046
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A61L2300/254—Enzymes, proenzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/418—Agents promoting blood coagulation, blood-clotting agents, embolising agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Materials Engineering (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Botany (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Secondary Cells (AREA)
  • Battery Electrode And Active Subsutance (AREA)
  • Chemical Vapour Deposition (AREA)
  • Laminated Bodies (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)

Abstract

La presente invención se refiere a películas a base de plasma y en particular a películas flexibles a base de plasma. La invención se refiere además para y a métodos para elaborar y usar las películas flexibles a base de plasma. Las modalidades de la invención han sido particularmente desarrolladas para elaborar películas flexibles a base de plasma útiles como un hemostato en el tratamiento y/o prevención de sangrados arteriales leves a severos, así como también como una lámina anti-adhesiva para reducir o prevenir el desarrollo de adhesiones inducidas por cirugía, como un parche para curar heridas, como un apósito para heridas, o como una película útil en la reparación de hernias. Modalidades de la invención serán descritas más adelante con referencia a estas aplicaciones. Sin embargo, se apreciará que la invención no se limita a este campo de uso particular.
MX2018014889A 2016-05-31 2017-05-31 Peliculas a base de plasma y metodos para elaborar y usar las mismas. MX2018014889A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662343840P 2016-05-31 2016-05-31
PCT/US2017/035159 WO2017210267A2 (en) 2016-05-31 2017-05-31 Plasma-based films and methods for making and using the same

Publications (1)

Publication Number Publication Date
MX2018014889A true MX2018014889A (es) 2019-04-08

Family

ID=59254013

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2018014889A MX2018014889A (es) 2016-05-31 2017-05-31 Peliculas a base de plasma y metodos para elaborar y usar las mismas.
MX2022001339A MX2022001339A (es) 2016-05-31 2018-11-30 Peliculas a base de plasma y metodos para elaborar y usar las mismas.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2022001339A MX2022001339A (es) 2016-05-31 2018-11-30 Peliculas a base de plasma y metodos para elaborar y usar las mismas.

Country Status (12)

Country Link
US (2) US11383001B2 (es)
EP (3) EP4194017A1 (es)
CN (2) CN114796630B (es)
AU (1) AU2017275577B2 (es)
BR (2) BR112018074591B1 (es)
CA (2) CA3024511A1 (es)
DK (2) DK3701973T3 (es)
ES (2) ES2900548T3 (es)
IL (2) IL263093B (es)
MX (2) MX2018014889A (es)
TR (1) TR2021016542A2 (es)
WO (1) WO2017210267A2 (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0808376D0 (en) 2008-05-08 2008-06-18 Bristol Myers Squibb Co Wound dressing
GB0817796D0 (en) 2008-09-29 2008-11-05 Convatec Inc wound dressing
GB201020236D0 (en) 2010-11-30 2011-01-12 Convatec Technologies Inc A composition for detecting biofilms on viable tissues
EP4162968A1 (en) 2010-12-08 2023-04-12 ConvaTec Technologies Inc. System for removing exudates from a wound site
JP6151186B2 (ja) 2010-12-08 2017-06-21 コンバテック・テクノロジーズ・インコーポレイテッドＣｏｎｖａｔｅｃ Ｔｅｃｈｎｏｌｏｇｉｅｓ Ｉｎｃ 創傷滲出液システム付属装置
CA2819475C (en) 2010-12-08 2019-02-12 Convatec Technologies Inc. Integrated system for assessing wound exudates
GB201115182D0 (en) 2011-09-02 2011-10-19 Trio Healthcare Ltd Skin contact material
GB2497406A (en) 2011-11-29 2013-06-12 Webtec Converting Llc Dressing with a perforated binder layer
CN105008611A (zh) 2012-12-20 2015-10-28 康沃特克科技公司 化学改性的纤维素纤维的处理
KR20190013725A (ko) 2016-03-30 2019-02-11 컨바텍 테크놀러지스 인크 상처 내의 미생물 감염의 검출
CA3019445A1 (en) 2016-03-30 2017-12-14 Synovo Gmbh Detecting microbial infection in wounds
KR20190026858A (ko) 2016-07-08 2019-03-13 컨바텍 테크놀러지스 인크 가요성 부압 시스템
CN109640904A (zh) 2016-07-08 2019-04-16 康沃特克科技公司 流体收集设备
AU2017292028B2 (en) 2016-07-08 2023-03-02 Convatec Technologies Inc. Fluid flow sensing
EP4360666A3 (en) 2017-11-16 2024-05-08 ConvaTec Limited Fluid collection apparatus
WO2020245656A1 (en) 2019-06-03 2020-12-10 Convatec Limited Methods and devices to disrupt and contain pathogens
US11331221B2 (en) 2019-12-27 2022-05-17 Convatec Limited Negative pressure wound dressing
US11771819B2 (en) 2019-12-27 2023-10-03 Convatec Limited Low profile filter devices suitable for use in negative pressure wound therapy systems
US11654057B2 (en) 2020-04-09 2023-05-23 Bio 54, Llc Devices for bleeding reduction and methods of making and using the same
US20230277474A1 (en) * 2020-08-31 2023-09-07 Vitruvian Medical Devices, Inc. Storage Stable Films Comprising Fibrin and/or Fibrinogen
US11642324B1 (en) 2022-03-01 2023-05-09 Bio 54, Llc Topical tranexamic acid compositions and methods of use thereof
IL315038A (en) 2022-03-09 2024-10-01 Octapharma Ag A template for applying a liquid on top of a plasma-based layer or on the basis of a freeze-sink material and a method for coating a plasma-based layer or a freeze-sink material
EP4262901B1 (en) * 2022-03-09 2024-02-07 Octapharma AG Biodegradable, non-porous medical device and methods for making and using the same

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2064439T3 (es) * 1988-05-02 1995-02-01 Project Hear Material adhesivo quirurgico.
JPH05192387A (ja) * 1990-11-08 1993-08-03 Matrix Pharmaceut Inc 生物医学的用途のための線維素／コラーゲン膜
ATE241340T1 (de) * 1994-02-17 2003-06-15 New York Blood Ct Inc Biologische bioadhäsive präparate, die fibrinkleber und liposomen enthalten, verfahren für ihre herstellung und verwendung
US20020131933A1 (en) * 1996-01-16 2002-09-19 Yves Delmotte Biopolymer membrane and methods for its preparation
US20040147024A1 (en) * 2000-02-10 2004-07-29 Crowe John H. Therapeutic platelets and methods
ES2173812B1 (es) * 2001-03-01 2003-12-16 Ct Investig Energeticas Ciemat Dermis artificial y metodo de obtencion.
US20070048387A1 (en) * 2005-09-01 2007-03-01 Edwards Jeffrey D Tissue disruption treatment and composition for use thereof
US8529958B2 (en) 2006-10-17 2013-09-10 Carmell Therapeutics Corporation Methods and apparatus for manufacturing plasma based plastics and bioplastics produced therefrom
CN102341130B (zh) * 2009-01-27 2017-11-10 雷德德莱斯有限公司 创伤敷料、用于制造创伤敷料的方法和设备以及其储存和用途
US20170105877A1 (en) * 2014-06-10 2017-04-20 M4 Medical Pty Ltd Wound dressing
US9848871B2 (en) * 2014-06-10 2017-12-26 Ethicon Llc Woven and fibrous materials for reinforcing a staple line

Also Published As

Publication number Publication date
US20210008243A1 (en) 2021-01-14
IL284877A (en) 2021-08-31
BR112018074591B1 (pt) 2022-07-12
EP4194017A1 (en) 2023-06-14
ES2900548T3 (es) 2022-03-17
WO2017210267A2 (en) 2017-12-07
US11383001B2 (en) 2022-07-12
DK3701973T3 (da) 2023-01-09
RU2018146094A3 (es) 2020-09-25
ES2936807T3 (es) 2023-03-22
CN114796630A (zh) 2022-07-29
CA3024511A1 (en) 2017-12-07
IL263093B (en) 2021-08-31
RU2018146094A (ru) 2020-07-09
WO2017210267A3 (en) 2018-02-15
RU2021119683A3 (es) 2022-02-25
BR122022006547B1 (pt) 2022-12-13
BR112018074591A2 (pt) 2019-03-12
RU2021119683A (ru) 2021-07-12
AU2017275577B2 (en) 2021-04-29
EP3701973B1 (en) 2022-10-26
CN109789245B (zh) 2022-10-18
EP3463498B1 (en) 2021-09-22
AU2017275577A1 (en) 2018-12-06
EP3463498A2 (en) 2019-04-10
MX2022001339A (es) 2022-03-11
US11383002B2 (en) 2022-07-12
US20200297893A1 (en) 2020-09-24
IL284877B (en) 2022-01-01
TR2021016542A2 (tr) 2022-01-21
CN114796630B (zh) 2024-06-25
EP3701973A1 (en) 2020-09-02
IL263093A (en) 2018-12-31
CA3224181A1 (en) 2017-12-07
DK3463498T3 (da) 2021-12-20
CN109789245A (zh) 2019-05-21

Similar Documents

Publication Publication Date Title
MX2022001339A (es) Peliculas a base de plasma y metodos para elaborar y usar las mismas.
CY1122480T1 (el) Μεθυλικη βαρδοξολονη για τη θεραπεια παχυσαρκιας
CA2897514C (en) Nanofibrillar polysaccharide for use in the control and prevention of contraction and scarring
MX2018011872A (es) Apositos extensibles.
EA202091964A1 (ru) КОМБИНИРОВАННЫЙ ПРОДУКТ НА ОСНОВЕ ИНГИБИТОРА Bcl-2 И ИНГИБИТОРА MDM2 И ЕГО ПРИМЕНЕНИЕ В ПРЕДУПРЕЖДЕНИИ И/ИЛИ ЛЕЧЕНИИ ЗАБОЛЕВАНИЙ
BR112017021396A2 (pt) composição em gel, filme e método para aplicação de uma composição em gel
MX2016009477A (es) Vendaje plegable para el tratamiento de heridas con presion negativa.
AU2012266095A8 (en) Wound contacting members and methods
MX2018015657A (es) Compuestos heterociclico como antibacterianos.
WO2019040106A3 (en) COMPOUNDS, RELATED SALTS AND METHODS FOR THE TREATMENT OF DISEASES
EP3151766A4 (en) Surgical implant for correction of hallux valgus or tailor's bunion
WO2019102380A8 (en) Therapeutic treatment of breast cancer based on c-maf status
MX2016014050A (es) Combinacion de un acido hialuronico y un polisacarido sulfatado.
CL2019000228A1 (es) Tratamiento conjunto contra tipos de cáncer hematológico.
AU2016201227A1 (en) Medical devices with sealing properties
GB2558315A (en) Patterned surfaces
ZA202306279B (en) Therapy of post-operative emesis with amisulpride
BR112021014281A2 (pt) Polímero superabsorvente e método de preparação para o mesmo
MX2018004480A (es) Pelicula de polietileno que tiene propiedades esteticas y de rendimiento unicas.
BR112021014295A2 (pt) Polímero superabsorvente e método de preparação para o mesmo
MX373977B (es) Agonistas alfa adrenergicos para el tratamiento de traumatismo de tejidos.
MX2020011002A (es) Combinacion que comprende inhibidor de hdac, inhibidor de lag-3 y un inhibidor de pd-1 o inhibidor de pd-l1 para el tratamiento del cancer.
PH12020551331A1 (en) Treatment and prevention of pre-eclampsia
MX2019007216A (es) Caucho de nitrilo que contiene grupo carboxilo, metodo para producir el mismo, composicion de caucho de nitrilo reticulable, y caucho reticulado.
PL3827978T3 (pl) Folia polimerowa i jej zastosowania